These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15090232)

  • 1. An interview with Maria L. Garcia, Ph.D., Senior Investigator, Merck Research Laboratories.
    Garcia ML
    Assay Drug Dev Technol; 2003 Oct; 1(5):605-10. PubMed ID: 15090232
    [No Abstract]   [Full Text] [Related]  

  • 2. An interview with Gregory J. Kaczorowski, Ph.D., Senior Director, Department of Ion Channels, Merck Research Laboratories, Rahway, NJ: interviewed by Vicki Glaser.
    Kaczorowski GJ
    Assay Drug Dev Technol; 2008 Apr; 6(2):137-42. PubMed ID: 18471071
    [No Abstract]   [Full Text] [Related]  

  • 3. Strength and honor through the pharmaceutical industry's embrace of green chemistry?
    Fortunak J; Confalone PN; Grosso JA
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):651-3. PubMed ID: 17987518
    [No Abstract]   [Full Text] [Related]  

  • 4. Can biochemistry drive drug discovery beyond simple potency measurements?
    Chène P
    Drug Discov Today; 2012 Apr; 17(7-8):388-95. PubMed ID: 22326379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug discovery: the leading edge.
    Chapman T
    Nature; 2004 Jul; 430(6995):109-15. PubMed ID: 15229608
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug discovery technology for ion channels.
    Lachnit WG; Costantin JL
    Drug Discov Today; 2002 Jun; 7(12):651-2. PubMed ID: 12110241
    [No Abstract]   [Full Text] [Related]  

  • 7. A return to the fundamentals of drug discovery?
    Williams M
    Curr Opin Investig Drugs; 2004 Jan; 5(1):29-33. PubMed ID: 14983970
    [No Abstract]   [Full Text] [Related]  

  • 8. Forging synergies in drug discovery.
    Nat Chem Biol; 2008 Feb; 4(2):83. PubMed ID: 18202672
    [No Abstract]   [Full Text] [Related]  

  • 9. Compendium of drugs commonly used in cell biology research.
    Cole NH
    Curr Protoc Cell Biol; 2001 May; Appendix 1():Appendix 1B. PubMed ID: 18228274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palladium coupling catalysts for pharmaceutical applications.
    Doucet H; Hierso JC
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):672-90. PubMed ID: 17987520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resurrection men dig through the drug graveyard: ARYx revives problem blockbuster drugs.
    Wolfson W
    Chem Biol; 2005 Nov; 12(11):1155-6. PubMed ID: 16298292
    [No Abstract]   [Full Text] [Related]  

  • 12. Data completeness--the Achilles heel of drug-target networks.
    Mestres J; Gregori-Puigjané E; Valverde S; Solé RV
    Nat Biotechnol; 2008 Sep; 26(9):983-4. PubMed ID: 18779805
    [No Abstract]   [Full Text] [Related]  

  • 13. A taste of the future.
    Sheridan C
    Nat Biotechnol; 2004 Oct; 22(10):1203-5. PubMed ID: 15470447
    [No Abstract]   [Full Text] [Related]  

  • 14. In biomarkers we trust?
    Baker M
    Nat Biotechnol; 2005 Mar; 23(3):297-304. PubMed ID: 15765081
    [No Abstract]   [Full Text] [Related]  

  • 15. High-throughput and parallel screening methods in asymmetric hydrogenation.
    Jäkel C; Paciello R
    Chem Rev; 2006 Jul; 106(7):2912-42. PubMed ID: 16836304
    [No Abstract]   [Full Text] [Related]  

  • 16. Putting nature back into drug discovery.
    Müller-Kuhrt L
    Nat Biotechnol; 2003 Jun; 21(6):602. PubMed ID: 12776140
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of discovery DMPK scientists in industry: where do we go from here?
    Moriwaki T
    Drug Metab Pharmacokinet; 2012; 27(2):169-70. PubMed ID: 22531680
    [No Abstract]   [Full Text] [Related]  

  • 18. Facts, figures and trends in lead generation.
    Deprez-Poulain R; Deprez B
    Curr Top Med Chem; 2004; 4(6):569-80. PubMed ID: 14965294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialic acids: carbohydrate moieties that influence the biological and physical properties of biopharmaceutical proteins and living cells.
    Byrne B; Donohoe GG; O'Kennedy R
    Drug Discov Today; 2007 Apr; 12(7-8):319-26. PubMed ID: 17395092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redesigner drugs.
    Dove A
    Nat Biotechnol; 2004 Aug; 22(8):953-7. PubMed ID: 15286643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.